By: Pirix.co
Reprai has launched a groundbreaking AI-powered solution designed to streamline and supercharge pharma marketing and sales in a move that could shake up the pharmaceutical industry. This platform enhances how drug companies interact with healthcare professionals (HCPs).
reprai’s AI-powered platform automates and optimizes promotional operations for pharmaceutical companies. The platform’s core AI, reREP, takes on the role of a traditional pharma sales representative, while reTOOLS boosts operational efficiency. Together, they offer a comprehensive solution to transform pharma companies’ engagement with HCPs.
“The pharmaceutical industry faces a uniquely challenging promotional landscape. Despite significant technological advances in medical science, the methods used to communicate these advances to healthcare professionals have remained unchanged and now are outdated and inefficient,” says Didem Aral, Founder and CEO of reprai.
Enhancing Efficiency in the Pharma Promotional Landscape
Marketing and sales outcomes often depend on a combination of sales representative visits, digital campaigns, peer influence, and clinical guidelines, making clear attribution difficult. Industry research suggests that many pharma companies face challenges linking sales results to specific marketing and sales activities. Additionally, the increasing difficulty for sales representatives to meet with HCPs is similar to how the digital evolution in our daily lives has impacted our expectations.
Embracing the Digital Age
reprai’s digital-first approach empowers pharma companies to connect with numerous HCPs at the click of a button. With 24/7 availability, HCPs can engage with the platform whenever it suits their schedule, whether early in the morning or late at night. This round-the-clock accessibility allows companies to expand their reach without additional strain, simultaneously delivering personalized, relevant information and resources to multiple HCPs.
reprai introduces a new era of communication between pharma and HCPs, making interactions more efficient, up-to-date, and to the point.
Will All Pharma Sales Representatives Lose Their Jobs?
Instead of replacing the pharmaceutical sales workforce, Reprai introduces a shift in the industry’s approach. AI representatives will initially work alongside existing teams, supporting their efforts rather than taking over entirely. Sales representatives with strong expertise may take on roles as trainers and specialists, overseeing AI systems and managing more complex interactions.
“This transformation is inevitable in the pharmaceutical industry, just as technology is reshaping other sectors,” says Didem Aral. “The most successful organizations will be those that effectively blend human expertise with AI capabilities.”
Background Behind the Innovation
Founded in 2024, reprai operates as a B2B SaaS solution in the pharmaceutical industry, bringing together expertise and cutting-edge technology. The company comprises seasoned founders with deep knowledge of the pharmaceutical industry, enabling the platform to address real-world challenges faced by actual pharma companies and HCPs.
Founder and CEO Didem Aral brings nearly 25 years of experience in marketing and creative industries to the venture. Her career spans traditional and digital platforms, including significant work with pharma giants such as Pfizer, Johnson & Johnson, MSD, Merck, Novo Nordisk, Takeda, and Bayer.
Her extensive background in medico-marketing and HCP communications provides an excellent basis for developing a solution that truly meets the needs of the pharmaceutical industry.
For more information and to book a demo, please visit the company’s website: https://reprai.com
Published by Anne C.
